Share price: 104.00p

Directorate change

5th November 2018

Cello Health plc (AIM: CLL), the global healthcare focused advisory group, is pleased to announce the appointment of Chris Jones as Non-Executive Chairman of the Group with immediate effect, following the retirement of Allan Rich from the Board.

Chris Jones has been a Non-Executive Director of Cello since October 2016. He was formerly Global Chairman and CEO of J Walter Thompson Co based in New York, part of WPP Group plc. Amongst other directorships, Chris is also a director of Becton Dickinson & Co, the major US-based multinational medical technology company.

Mark Scott, Chief Executive, commented: “The Board wishes to wholeheartedly thank Allan Rich for his invaluable contribution to Cello over the years from its inception. Chris knows the Group and the healthcare industry well and can help guide the Board through the Group’s next stage of growth and development.”

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150